Position in UTHR
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,437,383
-$156,411 QoQ
Shares Held
2,424
-25.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sequoia Financial Advisors, LLC holds $18,289,856 across 14 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
169,700 | $5,111,364 | |
| 2 | ZTS |
Zoetis Inc.
|
20,927 | $2,473,780 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
163,060 | $2,258,381 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
98,936 | $1,832,294 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,424 | $1,437,383 | |
| 6 | VTRS |
Viatris Inc
|
99,279 | $1,341,259 | |
| 7 | HLN |
Haleon plc
|
102,062 | $1,021,640 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
4,849 | $638,807 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,437,383 | 2,424 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,593,794 | 3,271 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $747,870 | 1,784 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $306,602 | 1,067 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $205,616 | 667 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $300,972 | 853 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $259,087 | 723 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $204,509 | 642 | Shares | Sole | 2024-07-15 | |
| No filing history on record for this holder in this stock. | ||||||